Drug Profile
Hepatitis A vaccine (Nothav) - GSK
Alternative Names: NothavLatest Information Update: 02 Aug 2023
Price :
$50
*
At a glance
- Originator Chiron
- Class Hepatitis A vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Hepatitis A
Most Recent Events
- 20 Apr 2006 Chiron Corporation has been acquired and merged into Novartis
- 16 Aug 1996 Launched for Hepatitis A (prevention) in Italy (IM)
- 03 Apr 1995 Preregistration for Hepatitis A (prevention) in Italy (IM)